UPClytics
View all cases

UPC CFI 607/2025

Jul 8, 2025·EP4241767 Unitary patent · NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Case details
Status
Case Closed
Action
Counterclaim for revocation
Category
Counterclaim for revocation
Parties
Claimants
Representatives
Respondents
Representatives
Division
The Hague LD
Technology
  • Chemistry
    Pharmaceuticals
Language
English
EPO Opposition
  • ModernaTX, Inc.Withdrawn2025-04-29
  • Merck Sharp & Dohme (UK) LimitedWithdrawn2025-07-23
  • Arrowhouse GmbHAdmissible2025-07-23
  • Keltie LLPAdmissible2025-07-23
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Patent revokedMedian days to first decision
All UPC37% (34/91)124
The Hague LDLockedLocked
Judge Edger BrinkmanLockedLocked
Judge Margot KokkeLockedLocked
Judge Samuel GranataLockedLocked
Judge Xavier Dorland-GalliotLockedLocked

At the UPC: Moderna Group (20 cases)·Arbutus Biopharma Corporation (12 cases)

This dispute contains 3 other proceedings

UPC APP 18039/2025·UPC APP 25212/2025·UPC APP 27016/2025

3 other defendants litigating the same or a related patent

UPC CFI 2562/2026·UPC CFI 2566/2026·UPC CFI 192/2025

Start a free trial to see how each one ended.

More cases: The Hague LD·2025

Document titleDatePublic
Case closed2026-08-25Not public
Order2026-08-25Not public
Order2026-08-25Not public
Hearing recording reference document2026-03-09Not public
Receipt2026-03-04Not public
Cover sheet2026-03-04Not public
Application document Defendant2026-03-04Not public
Receipt2026-02-27Not public
Cover sheet2026-02-27Not public
Document Claimant2026-02-27Not public